The Dow Jones index closed higher by 0.2% on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.

Bespoke Extracts

The Trade: Bespoke Extracts, Inc. ( BSPK ) CEO Michael Feinsod bought a total of 2,000 shares at an average price of $0.13. To acquire these shares, it cost around $268.

What's Happening: The company’s stock lost around 48% over the past six months.

What Bespoke Extracts Does: Bespoke Extracts Inc ( BSPK ) is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products.

Ocuphire Pharma

The Trade: Ocuphire Pharma, Inc. ( OCUP ) CEO George Magrath acquired a total of 5,000 shares at an average price of $1.75. To acquire these shares, it cost around $8,773.

What's Happening: On May 10, Ocuphire Pharma ( OCUP ) posted a wider-than-expected quarterly loss.

What Ocuphire Pharma Does: Ocuphire Pharma Inc ( OCUP ) is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders.

Duos Technologies

The Trade: Duos Technologies Group, Inc. ( DUOT ) CEO Charles Parker Ferry acquired a total of 3,773 shares at an average price of $2.70. The insider spent around $10,187 to buy those shares.

What's Happening: On May 13, Duos Technologies Group ( DUOT ) reported weaker than expected first-quarter sales.

What Duos Technologies Does: Duos Technologies Group Inc ( DUOT ) operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs.

Read More: Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month